Skip to main content
. 2013 May 1;36(5):699–708. doi: 10.5665/sleep.2630

Figure 4.

Figure 4

Tracing illustrating the development of raw genioglossus (GG) electromyogram (EMG) activity in a pig after administration of 10 mg of AVE0118 to each nostril (vertical arrow). The onset of action of the nasal formulation is delayed by approximately 30 min in line with the onset of inhibition of collapsibility (see Figure 3). EMG activity is given in arbitrary units.